- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 267/00 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
Patent holdings for IPC class C07D 267/00
Total number of patents in this class: 28
10-year publication summary
2
|
2
|
2
|
0
|
2
|
0
|
0
|
1
|
2
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Massachusetts Institute of Technology | 10080 |
4 |
The Trustees of Boston College | 195 |
3 |
Blade Therapeutics, Inc. | 19 |
2 |
ISP Investments Inc. | 459 |
2 |
Novartis AG | 10727 |
1 |
Bristol-myers Squibb Company | 4872 |
1 |
Merck Patent GmbH | 5814 |
1 |
FUJIFILM Corporation | 29489 |
1 |
National Taiwan University | 1230 |
1 |
ALFASIGMA S.p.A. | 490 |
1 |
C4X Discovery Limited | 23 |
1 |
The Government of The United States of America AS represented by The Secretary of The Department of Health and Human Services | 172 |
1 |
Hovione Farmaciencia, S.A. | 11 |
1 |
Kyushu University, National University Corporation | 1658 |
1 |
Medivir AB | 121 |
1 |
National University Corporation Kumamoto University | 390 |
1 |
Novintum Biotechnology GmbH | 9 |
1 |
Rigel Pharmaceuticals, Inc. | 538 |
1 |
Stemergie Biotechnology SA | 2 |
1 |
Capsugel Belgium | 3 |
1 |
Other owners | 1 |